Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Company    BMY

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Bristol Myers Squibb : Celebrity Whistleblower Attorney™ Mychal Wilson's Whistleblower Journey Premieres July 13th Primetime 8/7c On CBS

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/06/2018 | 06:51pm EDT

A thrilling look into the real-life David vs. Goliath story of Celebrity Whistleblower Attorney™ Mychal Wilson

LOS ANGELES, CALIFORNIA, UNITED STATES OF AMERICA, July 6, 2018 /EINPresswire.com/ -- The whistleblower journey of Mychal Wilson, Esq. will premiere primetime Friday, July 13th at 8/7c on CBS.

CBS’ “Whistleblower” is a docuseries that “takes a thrilling look into the real-life David vs. Goliath stories of heroic people who put everything on the line in order to expose illegal and often dangerous wrongdoing when major corporations rip off U.S. taxpayers.”

WHISTLEBLOWER takes a thrilling look into the real-life David vs. Goliath stories of heroic people who put everything on the line in order to expose illegal and often dangerous wrongdoing when major corporations rip off U.S. taxpayers. Hosted by attorney Alex Ferrer, a former judge and police officer, each hour introduces cases in which ordinary people step up to do the extraordinary by risking their careers, their families and even their lives to ensure others are not harmed or killed by unchecked, unethical corporate greed.

The premiere episode will feature the cases concerning pediatric dental chain Kool Smiles and Celebrity Whistleblower Attorney™ Mychal Wilson’s whistleblower journey against his former employer pharmaceutical giant Bristol-Myers Squibb.

"I would like to thank CBS, Emmy Award winner and Senior Executive Producer Susan Zirinsky (48 HOURS, 48 HOURS: NCIS), Executive Producers Alex Ferrer, Ted Eccles, Gail Zimmerman and Allen Alter, Producer Caroline Sommers, and Director of Photography Leigh Hubner for the opportunity tell my story," says Mychal Wilson, Esq.

WHISTLEBLOWER is produced by CBS News for CBS Television Studios.

Mychal Wilson, Esq. is now a successful relator and Qui Tam attorney who has assisted various Federal and State agencies in the recovery of over $580 million in American taxpayer's dollars, who recently launched his new 30 minute news series titled "The Whistleblower” with Mychal Wilson, Esq.

Attorney Wilson’s own show titled "The Whistleblower” is a weekly nonpartisan political news program which airs every Tuesday live at 10:00 pm Eastern and 7:00 pm Pacific, on Roku, Amazon Fire TV, and coming soon on Apple TV, DISH TV and on demand thereafter.

About Mychal Wilson:


Mychal Wilson is a Qui Tam attorney and Entertainment law attorney, who is also a former actor/producer (Sundance Film Festival and HBO, STARZ!), and top big pharma cardiovascular/diabetes pharmaceutical sales representative for Bristol-Myers Squibb.

Currently, Mychal Wilson serves as legal counsel on several sealed and high profile unsealed whistleblower cases such as the False Claims Act (FCA) matter of the misbranding spinal device case U.S. ex rel. Dan Abrams Company, LLC v. Medtronic, Case No. 2:15-cv-01212 (C.D. Cal.), and the intervened Texas Medicaid Fraud Prevention Act drug pricing case, State of Texas v. Lupin, Case No. D-1-GN-16-005758 (TX), and U.S. ex rel Alexander Volkhoff v. Janssen, et al, Case No. 2:16-cv-06987-RGK-RAO (C.D. Cal.) involving the illegal sales and marketing of some its opioid and other prescription drugs

Mychal has been a member of the SAG-AFTRA ("Screen Actors Guild") since 1993 and is a media personality who regularly serves as a legal analyst on numerous media outlets such as BBC, The Doctors TV Show, Newsmax TV, OANN, RT and 790 KABC Radio Dr. Drew Midday Live.

Mychal Wilson, Esq. is a member of the State Bar of California and admitted to practice law in the Eastern, Northern, Central and Southern United States District Courts of California, and the Supreme Court of the United States (SCOTUS).

Twitter: @mychalwilsonesq
www.mychalwilsonesq.com

CONTACT:
The Whisteblower Show Booking Inquiries: press@mychalwilsonesq.com 

Media Booking Inquiries: 212.246.6236, JayJones@AlwaysONPR.tv
  
SOURCE The Law Office of Mychal Wilson

Related Links
http://www.mychalwilsonesq.com

Mychal Wilson, Esq.
The Law Office of Mychal Wilson
(424) 252-4232
email us here

Dr. Wendy Walsh Discusses Sexual Harassment Allegations Regarding Former Fox Host Bill O’Reilly

Copyright 1995-2018 IPD Group, Inc. All Right Reserved. , source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BRISTOL-MYERS SQUIBB COMPA
03/22BRISTOL MYERS SQUIBB : Additional Proxy Soliciting Materials - Non-Management (d..
PU
03/20BRISTOL MYERS SQUIBB : Overheard
DJ
03/19BRISTOL MYERS SQUIBB : Correction to Bristol-Myers Squibb Overheard Article
DJ
03/19If This Is Failure, Show Me Success -- Overheard
DJ
03/19BRISTOL MYERS SQUIBB : Starboard Issues Investor Presentation Opposing Bristol-M..
PR
03/19BRISTOL MYERS SQUIBB : Files Investor Presentation Highlighting Significant Bene..
BU
03/18BRISTOL MYERS SQUIBB : Additional Proxy Soliciting Materials - Non-Management (d..
PU
03/18BRISTOL MYERS SQUIBB : Filing of certain prospectuses and communications in conn..
PU
03/15BRISTOL MYERS SQUIBB : Proxy Statment - Contested Solicitations (definitive)
PU
03/15BRISTOL MYERS SQUIBB : Mutual funds start to put their mouth where their money i..
RE
More news
Financials ($)
Sales 2019 23 977 M
EBIT 2019 6 881 M
Net income 2019 6 782 M
Finance 2019 3 655 M
Yield 2019 3,41%
P/E ratio 2019 11,89
P/E ratio 2020 11,52
EV / Sales 2019 3,13x
EV / Sales 2020 2,85x
Capitalization 78 630 M
Chart BRISTOL-MYERS SQUIBB COMPANY
Duration : Period :
Bristol-Myers Squibb Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQUIBB COMPA
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 57,0 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
Giovanni Caforio Chairman & Chief Executive Officer
Johanna Mercier President & Head-US Commercial
Charles A. Bancroft CFO, EVP & Head-Global Business Operations
Paul von Autenried Chief Information Officer & Senior Vice President
Thomas James Lynch Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BRISTOL-MYERS SQUIBB COMPANY-5.89%78 630
JOHNSON & JOHNSON6.09%367 729
NOVARTIS10.85%239 412
PFIZER-4.12%235 119
ROCHE HOLDING LTD.11.20%234 784
MERCK AND COMPANY8.56%214 112